Thrombotic complications following liver resection for colorectal metastases are preventable
Abstract
Venous thromboembolism in terms of deep venous thrombosis (DVT) or pulmonary embolism (PE) is a well-recognized cause of significant morbidity in patients undergoing resectional surgery for carcinomas [ 1 x [1] Lee, A.Y. and Levine, M.N. Venous thrombolembolism and cancer: risks and outcomes. Circulation. 2003; 107: 117–121 Crossref | Google Scholar See all References , 2 x [2] Thodiyil, P.A., Walsh, D.C., and Kakkar, A.K. Thromboprophylaxis in the cancer patient. Acta Hematol. 2001; 106: 73–80 Crossref | PubMed | Scopus (38) | Google Scholar See all References , 3 x [3] Svendsen, E. and Karwinski, B. Prevalence of pulmonary embolism at necropsy in patients with cancer. J Clin Pathol. 1989; 42: 805–809 Crossref | PubMed | Scopus (73) | Google Scholar See all References , 4 x [4] Geerts, W.H., Pineo, G.F., and Heit, J.A. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004; 126: 338S–400S Crossref | PubMed | Scopus (2203) | Google Scholar See all References ]. The relative risk of thrombosis compared to patients without tumors is 4 times, increasing to 6.5 times for patients who have also received chemotherapy [ 5 x [5] Heit, J.A., Silverstein, M.D., and Mohr, D.N. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000; 160: 809–815 Crossref | PubMed | Scopus (1359) | Google Scholar See all References ] [5] . Furthermore, patients with thromboembolic disease have a 3-fold risk of pulmonary embolism. A number of risk factors for thromboembolism have been recognized (Table I Table I ) [ 6 x [6] Geerts, W.H., Heit, J.A., and Clagett, G.P. Prevention of thromboembolism. Chest. 2001; 119: 132S (75S) Crossref | PubMed | Scopus (1494) | Google Scholar See all References ] [6] . The precise reason for the increased prevalence of thromboembolic events in patients with cancer is unclear, although in many cases the thromboembolism is attributed to a hypercoaguable state seen as part of the paraneoplastic syndrome.Keywords
This publication has 30 references indexed in Scilit:
- American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With CancerJournal of Clinical Oncology, 2007
- Hypercoagulability after partial liver resectionThrombosis and Haemostasis, 2007
- Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal MetastasesAnnals of Surgery, 2005
- Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)Annals of Surgery, 2004
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver MetastasesAnnals of Surgery, 2004
- Venous Thromboembolism and Cancer: Risks and OutcomesCirculation, 2003
- Donor safety in living related liver transplantation: Underestimation of the risks for deep vein thrombosis and pulmonary embolismLiver Transplantation, 2002
- Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBritish Journal of Surgery, 2001
- Prevention of Venous Thromboembolism in Cancer PatientsSeminars in Thrombosis and Hemostasis, 1999
- Prevalence of pulmonary embolism at necropsy in patients with cancer.Journal of Clinical Pathology, 1989